The L-Type Ca2+ Channel as a Therapeutic Target in Heart Disease

E-ISSN： 1875-533x|16|26|3341-3358

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.16, Iss.26, 2009-09, pp. : 3341-3358

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Effect of Acute Hypoxia on Excitability in the Heart and the L-Type Calcium Channel as a Therapeutic Target

Current Drug Discovery Technologies, Vol. 5, Iss. 4, 2008-12 ,pp. : 302-311

Bentham Science Publishers

Access to resources Recommend Favorite

L-type Ca 2+ channels of the embryonic mouse heart

By Klugbauer N. Welling A. Specht V. Seisenberger C. Hofmann F.

European Journal of Pharmacology, Vol. 447, Iss. 2, 2002-07 ,pp. : 279-284

Elsevier

Access to resources Recommend Favorite

A novel benzothiazine Ca 2+ channel antagonist, semotiadil, inhibits cardiac L-type Ca 2+ currents

By Koidl B. Miyawaki N. Tritthart H.A.

European Journal of Pharmacology, Vol. 322, Iss. 2, 1997-03 ,pp. : 243-247

Elsevier

Access to resources Recommend Favorite

pH-dependent block of the L-type Ca 2+ channel current by diltiazem in human mesenteric arterial myocytes

By Smirnov S.V. Aaronson P.I.

European Journal of Pharmacology, Vol. 360, Iss. 1, 1998-10 ,pp. : 81-90

Elsevier

Access to resources Recommend Favorite

Antidystonic effects of L-type Ca 2+ channel antagonists in a hamster model of idiopathic dystonia

By Richter A. Loscher W.

European Journal of Pharmacology, Vol. 300, Iss. 3, 1996-04 ,pp. : 197-202

Elsevier

Access to resources Recommend Favorite